- Jeffrey L. Carson, MD;
 - Brenda J. Grossman, MD, MPH;
 - Steven Kleinman, MD;
 - Alan T. Tinmouth, MD;
 - Marisa B. Marques, MD;
 - Mark K. Fung, MD, PhD;
 - John B. Holcomb, MD;
 - Orieji Illoh, MD;
 - Lewis J. Kaplan, MD;
 - Louis M. Katz, MD;
 - Sunil V. Rao, MD;
 - John D. Roback, MD, PhD;
 - Aryeh Shander, MD;
 - Aaron A.R. Tobian, MD, PhD;
 - Robert Weinstein, MD;
 - Lisa Grace Swinton McLaughlin, MD; and
 - Benjamin Djulbegovic, MD, PhD,
 - for the Clinical Transfusion Medicine Committee of the AABB*
 
+ Author Affiliations
Abstract
Description: Although 
approximately 85 million units of red blood cells (RBCs) are transfused 
annually worldwide, transfusion practices
                        vary widely. The AABB (formerly, the American 
Association of Blood Banks) developed this guideline to provide clinical
 recommendations
                        about hemoglobin concentration thresholds and 
other clinical variables that trigger RBC transfusions in 
hemodynamically stable
                        adults and children.
                     
Methods: These 
guidelines are based on a systematic review of the literature on 
randomized clinical trials evaluating transfusion
                        thresholds. We performed a literature search 
from 1950 to February 2011 with no language restrictions. We examined 
the proportion
                        of patients who received any RBC transfusion and
 the number of RBC units transfused to describe the effect of 
restrictive
                        transfusion strategies on RBC use. To determine 
the clinical consequences of restrictive transfusion strategies, we 
examined
                        overall mortality, nonfatal myocardial 
infarction, cardiac events, pulmonary edema, stroke, thromboembolism, 
renal failure,
                        infection, hemorrhage, mental confusion, 
functional recovery, and length of hospital stay.
                     
Recommendation 1: The AABB recommends adhering to a restrictive transfusion strategy (7 to 8 g/dL) in hospitalized, stable patients (Grade:
                        strong recommendation; high-quality evidence).
                     
Recommendation 2: The 
AABB suggests adhering to a restrictive strategy in hospitalized 
patients with preexisting cardiovascular disease and
                        considering transfusion for patients with 
symptoms or a hemoglobin level of 8 g/dL or less (Grade: weak 
recommendation; moderate-quality
                        evidence).
                     
Recommendation 3: The 
AABB cannot recommend for or against a liberal or restrictive 
transfusion threshold for hospitalized, hemodynamically
                        stable patients with the acute coronary syndrome
 (Grade: uncertain recommendation; very low-quality evidence).
                     
Recommendation 4: The 
AABB suggests that transfusion decisions be influenced by symptoms as 
well as hemoglobin concentration (Grade: weak recommendation;
                        low-quality evidence).
                     
No comments:
Post a Comment